Skull base meningioma - comparison of intensity-modulated radiotherapy planning techniques using the moduleaf micro-multileaf collimator and helical tomotherapy

Clinical Oncology

Volumn 22, Issue 3, 2010, Pages 179-184

  Estall, V ^a   Fairfoul, J ^b   Jena, R ^b   Jefferies, S J ^b   Burton, K E ^b   Burnet, N G ^b,c  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

IMRT; Meningioma; Skull base; Tomotherapy

Indexed keywords

ARTICLE; BRAIN STEM; CLINICAL ARTICLE; COLLIMATOR; CONTROLLED STUDY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTERMETHOD COMPARISON; MENINGIOMA; PETROUS BONE; PRIORITY JOURNAL; QUALITY CONTROL; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; RADIATION SAFETY; RADIATION USE EFFICIENCY; SKULL BASE TUMOR; TOMOTHERAPY; TREATMENT DURATION; TREATMENT PLANNING;

HUMANS; MENINGEAL NEOPLASMS; MENINGIOMA; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; SKULL BASE NEOPLASMS;

EID: 77950038672     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2010.01.004     Document Type: Article

References (22)

1. Coke C., Corn B., Werner-Wasik M., et al. Atypical and malignant meningiomas: an outcome report of seventeen cases. J Neurooncol 1998, 39:65-70.
2. Hug E., Devries A., Thornton A., et al. Management of atypical and malignant meningiomas: role of high-dose, 3D-conformal radiation therapy. J Neurooncol 2000, 48:151-160.
3. Milosevic M.F., Frost P.J., Laperriere N.J., et al. Radiotherapy for atypical or malignant intracranial meningioma. Int J Radiat Oncol Biol Phys 1996, 34:817-822.
4. Goldsmith B., Wara W., Wilson C., et al. Postoperative irradiation for subtotally resected meningiomas. A retrospective analysis of 140 patients treated from 1967 to 1990. J Neurosurg 1994, 80:195-201.
5. Baumert B.G., Norton I., Davis J. Intensity modulated stereotactic radiotherapy vs stereotactic conformal radiotherapy for the treatment of meningioma located predominantly in the skull base. Int J Radiat Oncol Biol Phys 2003, 57:580-592.
6. Estall V.J., Burnet N., Jena R., Eaton D. IMRT plan optimisation for skull base lesions: planning class solutions. Radiat Oncol 2008, 88(2):S418.
7. Soisson E.T., Tome W.A., Richards G.M., Mehta M.P. Comparison of linac based fractionated stereotactic radiotherapy and tomotherapy treatment plans for skull-base tumours. Radiother Oncol 2006, 78:313-321.
8. Yartsev S., Kron T., Cozzi L., Fogliata A., Bauman G. Tomotherapy planning of small brain tumours. Radiother Oncol 2005, 74:49-52.
9. Emami B., Lyman J., Brown A., et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991, 21(1). pp. 109-122.
10. Parsons J.T., Bova F.J., Fitzgerald C.R., Mendenhall W.M., Million R.R. Radiation optic neuropathy after megavoltage external beam irradiation: analysis of time dose factors. Int J Radiat Oncol Biol Phys 1994, 30(4):755-763.
11. Debus J., Wuendrich M., Pirzkall A., et al. High efficacy of fractionated stereotactic radiotherapy of large base of skull meningiomas - long term results. J Clin Oncol 2001, 19(15):3547-3553.
12. Debus J., Hug E.B., Liedsch N.J., et al. Brainstem tolerance to conformal radiotherapy of skull base tumours. Int J Radiat Oncol Biol Phys 1997, 39(5):967-975.
13. Parsons J.T., Bova F.J., Fitzgerald C.R., Mendenhall W.M., Million R.R. Radiation retinopathy after external-beam irradiation: analysis of time dose factors. Int J Radiat Oncol Biol Phys 1994, 30(4):765-773.
14. Henk J.M., Whitelocke R.A., Warrington A.P., et al. Radiation dose to the lens and cataract formation. Int J Radiat Oncol Biol Phys 1993, 25(5):815-820.
15. Coderre J.A., Morris G.M., Micca P.L., et al. Late effects of radiation on the central nervous system: role of vascular endothelial damage and glial stem cell survival. Radiat Res 2006, 166(3):495-503.
16. Lyubimova M., Hopewell J.W. Experimental evidence to support the hypothesis that damage to vascular endothelium plays the primary role in the development of late radiation-induced CNS injury. Br J Radiol 2004, 77:488-492.
17. Takeda A., Shigematsu N., Suzuki S., et al. Late retinal complications of radiation therapy for nasal and paranasal malignancies: relationship between irradiated-dose area and severity. Int J Radiat Oncol Biol Phys 1999, 44(3):599-605.
18. Daley M.E., Chen A.M., Bucci M.K., et al. Intensity-modulated radiation therapy for malignancies of the nasal cavities and paranasal sinus. Int J Radiat Oncol Biol Phys 2007, 67(1):151-157.
19. Schmiegelow M., Lassen S., Weber L., Poulsen H.S., Hertz H., Muller J. Dosimetry and growth hormone deficiency following cranial irradiation of childhood brain tumours. Med Pediatr Oncol 1999, 33(6):564-571.
20. Merchant T.E., Goloubeva O., Pritchard D.L., et al. Radiation dose-volume effects on growth hormone secretion. Int J Radiat Oncol Biol Phys 2002, 52(5):1264-1270.
21. Pai H.H., Thornton A., Katznelson L., et al. Hypothalamic/pituitary function following high dose conformal radiotherapy to the base of skull: demonstration of a dose effect relationship using dose volume histogram analysis. Int J Radiat Oncol Biol Phys 2001, 49(4):1079-1092.
22. Niemierko A. Reporting and analysing dose distributions: a concept of equivalent uniform dose. Med Phys 1997, 24:103-110.